Interleukin 6 −174 G/C Promoter Polymorphism and Risk of Coronary Heart Disease-Reference-Cited by-同舟云学术

Interleukin 6 −174 G/C Promoter Polymorphism and Risk of Coronary Heart Disease

Published:2006-01 Issue:1 Volume:26 Page:212-217
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Sie Mark P.S.¹,Sayed-Tabatabaei Fakhredin A.¹,Oei Hok-Hay S.¹,Uitterlinden André G.¹,Pols Hubert A.P.¹,Hofman Albert¹,van Duijn Cornelia M.¹,Witteman Jacqueline C.M.¹

Affiliation:

1. From the Departments of Epidemiology and Biostatistics (M.P.S.S., F.A.S.-T., H.-H.S.O., A.G.U., H.A.P.P., A.H., C.M.v.D., J.C.M.W.) and Internal Medicine (M.P.S.S., A.G.U., H.A.P.P.), Erasmus Medical Center, Rotterdam, the Netherlands.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Atherosclerosis — An Inflammatory Disease

2. Long-term (≥8 years) outcome after palmaz-schatz stent implantation

3. Atherosclerosis is an inflammatory disease

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis;2024-02-14

2. Study of the rs1800795 polymorphism of the <i>IL6</i> gene to verify the clinical portrait of a patient with chronic heart failure: gender aspects;Consilium Medicum;2022-12-15

3. An interleukin 6-based genetic risk score strengthened with interleukin 10 polymorphisms associated with long-term kidney allograft outcomes;American Journal of Transplantation;2022-12

4. Clinical relevance of IL-6 gene rs1800795 polymorphism in patients with ischemic heart disease and chronic heart failure;HERALD of North-Western State Medical University named after I.I. Mechnikov;2022-09-08

5. The Role of Plasma Interleukin-6 Levels on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk Scores in Javanese Patients with Chronic Kidney Disease;Journal of Personalized Medicine;2022-07-10